Patients and the public deserve big changes in evaluation of drugs

被引：59

作者：

Garattini, Silvio ^{[1
]}

Chalmers, Iain ^{[2
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy

[2] Summertown Pavil, Oxford OX2 7LG, England

来源：

BRITISH MEDICAL JOURNAL | 2009年 / 338卷

关键词：

PHARMACEUTICAL-INDUSTRY; RANDOMIZED-TRIALS; HEALTH; INFORMATION; DISCLOSURE; LAW;

D O I：

10.1136/bmj.b1025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 30 条

[1] [Anonymous], SIGNIFICANCE
[2] *ASS BRIT PHARM IN, 2008, ABPI BEST PRACT MOD
[3] Drug industry weakens US bill about disclosure of gifts to doctors
Burton, Bob
[J]. BRITISH MEDICAL JOURNAL, 2008, 336 (7656): : 1268 - 1268
[4] CAPO IV, 2003, GAZZETTA UFFICIA 1 S, V274, P95
[5] Chalmers I, 2005, CLIN TRIALS, V2, P229
[6] From optimism to disillusion about commitment to transparency in the medico-industrial complex
Chalmers, Iain
[J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (07) : 337 - 341
[7] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles
Chan, AW
Hróbjartsson, A
Haahr, MT
Gotzsche, PC
Altman, DG
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20): : 2457 - 2465
[8] *CMR INT, 2006, 2006 GLOB R D PERF M, P7
[9] UK government will tighten law on trial results after weaknesses found in safety legislation
Coombes, Rebecca
[J]. BRITISH MEDICAL JOURNAL, 2008, 336 (7644): : 576 - 577
[10] *DEP TRAD IND, R D SCOR 2006 TOP 80